Goldman Sachs analyst Adam Bubes raised the firm’s price target on Jacobs (J) to $163 from $158 and keeps a Buy rating on the shares after its Q1 earnings beat. The firm is positive on rising visibility of the company’s organic growth following a strong 2-times book-to-bill and continued double-digit pipeline growth, led by Life Sciences & Advanced Manufacturing, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on J:
- Jacobs price target raised to $175 from $174 at UBS
- Jacobs price target raised to $160 from $156 at RBC Capital
- Jacobs selected by the Gulf Coast Protection District
- Jacobs price target lowered to $143 from $146 at Baird
- Solid Q1 Execution and Strategic Moves Balanced by Valuation and Execution Risk Drive Hold Rating on Jacobs